283 related articles for article (PubMed ID: 18185481)
1. Evaluation and management of Lynch syndrome.
Boland CR
Clin Adv Hematol Oncol; 2007 Nov; 5(11):851,873. PubMed ID: 18185481
[No Abstract] [Full Text] [Related]
2. Screening to detect Lynch syndrome and prevent hereditary cancers in relatives.
Haddow JE; Palomaki GE
J Med Screen; 2011; 18(4):167-8. PubMed ID: 22184732
[No Abstract] [Full Text] [Related]
3. Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?
Ponti G; Ruini C; Tomasi A
Dis Colon Rectum; 2015 Jan; 58(1):141-2. PubMed ID: 25489705
[No Abstract] [Full Text] [Related]
4. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).
Rahner N; Steinke V; Schlegelberger B; Olschwang S; Eisinger F; Hutter P
Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20104243
[No Abstract] [Full Text] [Related]
5. Establishing a clinical and molecular diagnosis for hereditary colorectal cancer syndromes: Present tense, future perfect?
Jansen M; Menko FH; Brosens LA; Giardiello FM; Offerhaus GJ
Gastrointest Endosc; 2014 Dec; 80(6):1145-55. PubMed ID: 25434663
[No Abstract] [Full Text] [Related]
6. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.
Rahner N; Steinke V; Schlegelberger B; Eisinger F; Hutter P; Olschwang S
Eur J Hum Genet; 2013 Jan; 21(1):. PubMed ID: 22892529
[No Abstract] [Full Text] [Related]
7. Anticipating phenotypic differences from genetic mutations.
You YN
Dis Colon Rectum; 2015 Jan; 58(1):143-4. PubMed ID: 25489706
[No Abstract] [Full Text] [Related]
8. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
Usha L; Dewdney SB; Buckingham LE
JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
[No Abstract] [Full Text] [Related]
9. Advances in defective mismatch repair colon cancer.
Sargent DJ
Clin Adv Hematol Oncol; 2008 Sep; 6(9):639-41. PubMed ID: 18827786
[No Abstract] [Full Text] [Related]
10. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
11. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
Hall MJ
J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
13. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.
Boland CR; Koi M; Chang DK; Carethers JM
Fam Cancer; 2008; 7(1):41-52. PubMed ID: 17636426
[TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
[TBL] [Abstract][Full Text] [Related]
15. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
16. [Recent advances and future development on Lynch syndrome-associated endometrial cancer].
Ning Y; Wang Y; Wang YY; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913
[No Abstract] [Full Text] [Related]
17. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
Hampel H
J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
[TBL] [Abstract][Full Text] [Related]
19. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.
Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH
Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892
[TBL] [Abstract][Full Text] [Related]
20. Epitope-positive truncating MLH1 mutation and loss of PMS2: implications for IHC-directed genetic testing for Lynch syndrome.
Zighelboim I; Powell MA; Babb SA; Whelan AJ; Schmidt AP; Clendenning M; Senter L; Thibodeau SN; de la Chapelle A; Goodfellow PJ
Fam Cancer; 2009; 8(4):501-4. PubMed ID: 19672700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
